[go: up one dir, main page]

NO20001847D0 - Ny anvendelse av forbindelser for anti-kløe-aktivitet - Google Patents

Ny anvendelse av forbindelser for anti-kløe-aktivitet

Info

Publication number
NO20001847D0
NO20001847D0 NO20001847A NO20001847A NO20001847D0 NO 20001847 D0 NO20001847 D0 NO 20001847D0 NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 D0 NO20001847 D0 NO 20001847D0
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
English (en)
Other versions
NO20001847L (no
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847L publication Critical patent/NO20001847L/no
Publication of NO20001847D0 publication Critical patent/NO20001847D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20001847A 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet NO20001847D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847L NO20001847L (no) 2000-04-10
NO20001847D0 true NO20001847D0 (no) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847D0 (no) 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet

Country Status (18)

Country Link
EP (1) EP1030666A4 (no)
JP (1) JP2001520196A (no)
KR (1) KR20010031149A (no)
CN (1) CN1306426A (no)
AR (1) AR015966A1 (no)
AU (1) AU740875B2 (no)
BR (1) BR9814080A (no)
CA (1) CA2306985A1 (no)
CO (1) CO4810374A1 (no)
CZ (1) CZ20001376A3 (no)
HU (1) HUP0003792A3 (no)
IL (1) IL135581A0 (no)
NO (1) NO20001847D0 (no)
NZ (1) NZ503551A (no)
PL (1) PL341062A1 (no)
TR (1) TR200001040T2 (no)
WO (1) WO1999020280A1 (no)
ZA (1) ZA989450B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526531A (en) 2001-01-31 2005-02-25 Pfizer Prod Inc Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CA2436551A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
US20060258703A1 (en) * 2003-07-17 2006-11-16 Ono Pharmaceutical Co., Ltd. Remedy for pruritus comprising piperidine derivative as the active ingredient
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
BRPI0507604A (pt) * 2004-02-14 2007-07-03 Smithkline Beecham Corp medicamentos com atividade de receptor hm74a
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
PE20070405A1 (es) 2005-08-10 2007-05-06 Smithkline Beecham Corp Compuestos derivados de xantina como agonistas del receptor de acido nicotinico hm74a
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
CN101389612B (zh) * 2006-02-21 2011-09-21 卫材R&D管理有限公司 喹唑啉衍生物
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル ｎ－［３－（６，７－ジメトキシ－２－メチルアミノキナゾリン－４－イル）フェニル］テレフタラミックアシッドの結晶、非晶質体または塩
US8513269B2 (en) 2007-08-17 2013-08-20 Eisai R&D Management Co., Ltd. Preparation for external use
AU2008290000B2 (en) 2007-08-17 2012-05-10 Eisai R & D Management Co., Ltd. Method for producing quinazoline derivative
US20140121240A1 (en) * 2011-06-28 2014-05-01 Maruho Co., Ltd. Novel pharmaceutical composition
JP6678685B2 (ja) 2015-01-30 2020-04-08 上海珊▲頓▼医▲薬▼科技有限公司Ｓｈａｎｔｏｎ Ｐｈａｒｍａ Ｃｏ．， Ｌｔｄ． 尿酸性または痛風性疾患の予防または治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563168B1 (en) * 1990-12-21 2000-07-05 Beecham Group Plc Xanthine derivatives
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
EP0912568B1 (en) * 1996-05-15 2002-11-20 ALTANA Pharma AG imidazopyridines
ATE248167T1 (de) * 1997-03-07 2003-09-15 Altana Pharma Ag Tetrazole derivate
EP0998300A1 (en) * 1997-03-18 2000-05-10 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
WO1998055481A1 (en) * 1997-06-03 1998-12-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
CN1306426A (zh) 2001-08-01
PL341062A1 (en) 2001-03-26
KR20010031149A (ko) 2001-04-16
CZ20001376A3 (cs) 2002-06-12
WO1999020280A1 (en) 1999-04-29
CO4810374A1 (es) 1999-06-30
NZ503551A (en) 2002-05-31
JP2001520196A (ja) 2001-10-30
AU740875B2 (en) 2001-11-15
AR015966A1 (es) 2001-05-30
ZA989450B (en) 1999-04-19
BR9814080A (pt) 2000-09-26
HUP0003792A2 (hu) 2001-10-28
HUP0003792A3 (en) 2001-12-28
NO20001847L (no) 2000-04-10
EP1030666A1 (en) 2000-08-30
TR200001040T2 (tr) 2001-01-22
CA2306985A1 (en) 1999-04-29
AU1093899A (en) 1999-05-10
IL135581A0 (en) 2001-05-20
EP1030666A4 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
IS5354A (is) Ný efnasambönd
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
PT996622E (pt) Novos compostos heterociclicos espiroazabiciclicos
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
NO20015855D0 (no) Ny anvendelse av forbindelser som antibakterielle midler
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID22878A (id) Komposisi aktif secara terapi
NO993298D0 (no) Ny fremgangsmÕte
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24677A (id) Kombinasi senyawa aktif fungisidal
NO995796D0 (no) Ny fremgangsmåte
ID24270A (id) Penghilang sumbatan keratotik
FI963531A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
FI963532A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
ID23437A (id) Penghilang sumbatan keratotik
ID24694A (id) Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
NO963764D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
NO963762D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
SE9704839D0 (sv) New compounds
SE9702535D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application